Mayne Pharma Group Limited (ASX:MYX – Get Rating) insider Frank Condella purchased 3,210 shares of the company's stock in a transaction dated Monday, March 27th. The stock was purchased at an average price of A$3.52 ($2.34) per share, with a total value of A$11,289.57 ($7,526.38).
Frank Condella also recently made the following trade(s):
Get
Mayne Pharma Group alerts:
- On Friday, March 24th, Frank Condella bought 17,788 shares of Mayne Pharma Group stock. The stock was purchased at an average price of A$3.52 ($2.35) per share, with a total value of A$62,684.91 ($41,789.94).
Mayne Pharma Group Price Performance
The company has a debt-to-equity ratio of 10.18, a current ratio of 1.45 and a quick ratio of 0.62.
About Mayne Pharma Group
(Get Rating)
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products.
Read More
- The Bottom Is In For McCormick & Company
- Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
- Roku And The 20% Rally That's About To Start
- It's Rally-On! For PVH Corp. But How High Can It Go?
- Don't Be Fooled by These 3 Value Traps
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
梅恩製藥集團有限公司(ASX:MYX-GET評級)內部人士Frank Condella在3月27日星期一的交易中購買了3210股該公司股票。該股是以每股3.52澳元(2.34美元)的平均價格收購的,總價值為11,289.57澳元(7,526.38美元)。
弗蘭克·康德拉最近還進行了以下交易:
到達
梅恩製藥集團警報:
- 3月24日,星期五,Frank Condella購買了17,788股Mayne Pharma Group股票。該股是以每股3.52澳元(2.35美元)的平均價格收購的,總價值為62,684.91澳元(41,789.94美元)。
Mayne Pharma集團價格表現
該公司的債務權益比為10.18,流動比率為1.45,速動比率為0.62。
關於梅恩製藥集團
(獲取評級)
梅恩製藥集團有限公司是一家專業製藥公司,在澳大利亞、紐西蘭、美國、加拿大、歐洲和亞洲製造和銷售品牌和仿製藥產品。該公司通過四個部門運營:公制合同服務、國際、品牌產品和投資組合產品。
閱讀更多內容
- 麥考密克公司的底線已經到了
- 沃爾格林靴子聯盟:藍籌股,高收益扭虧為盈
- Roku和即將開始的20%拉力賽
- 這是拉力賽!但對PVH公司來說,它能漲到多高呢?
- 不要被這三個價值陷阱愚弄了
接受Mayne Pharma Group Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Mayne Pharma Group和相關公司的最新新聞和分析師評級的每日簡要摘要。